Article
New class of precision antimicrobials redefines role of Clostridium difficile S-layer in virulence and viability.
Science translational medicine - 6 Sept 2017
Kirk Joseph A, Gebhart Dana, Buckley Anthony M, Lok Stephen, Scholl Dean, Douce Gillian R, Govoni Gregory R, Fagan Robert P
Abstract excerpt
There is a medical need for antibacterial agents that do not damage the resident gut microbiota or promote the spread of antibiotic resistance. We recently described a prototypic precision bactericidal agent, Av-CD291.2, which selectively kills specific Clostridium difficile strains and prevents them from colonizing mice. We have since selected two Av-CD291.2-resistant mutants that have a surface (S)-layer-null...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
